Seminars in Cancer Biology

Introduction
pp. 1-2(2)
Author: Ferrone S.

HLA class I antigen abnormalities and immune escape by malignant cells
pp. 3-13(11)
Authors: Seliger B.; Cabrera T.; Garrido F.; Ferrone S.

Immunodominance and tumor escape
pp. 25-31(7)
Authors: Schreiber H.; Wu T.H.; Nachman J.; Kast W.M.

Tumour escape from immune surveillance through dendritic cell inactivation
pp. 33-42(10)
Authors: Vicari A.P.; Caux C.; Trinchieri G.

Tumor-induced death of immune cells: its mechanisms and consequences
pp. 43-50(8)
Author: Whiteside T.L.

Defective death receptor signaling as a cause of tumor immune escape
pp. 51-55(5)
Authors: French L.E.; Tschopp J.

Tumor cell recognition by natural killer cells
pp. 57-61(5)
Author: Long E.O.

Strategies to overcome immune ignorance and tolerance
pp. 63-71(9)
Authors: Perales M-A.; Blachere N.E.; Engelhorn M.E.; Ferrone C.R.; Gold J.S.; Gregor P.D.; Noffz G.; Wolchok J.D.; Houghton A.N.

Tumor immunology—towards a paradigm of reciprocal research
pp. 73-80(8)
Authors: Drake C.G.; Pardoll e.M.

Assumptions of the tumor ‘escape’ hypothesis
pp. 81-86(6)
Authors: Restifo N.P.; Antony P.A.; Finkelstein S.E.; Leitner W.W.; Surman D.R.; Theoret M.R.; Touloukian C.E.

Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy
pp. 403-405(3)
Authors: Ruiz-Cabello F.; Cabrera T.; Lopez-Nevot M-A.; Garrido F.